View of Assessment of Serum Small Mothers Against Decapentaplegic 2 (SMAD2) in Type 2 Diabetic Patients with Early and Chronic Diabetic Nephropathy

Return to Article Details Assessment of Serum Small Mothers Against Decapentaplegic 2 (SMAD2) in Type 2 Diabetic Patients with Early and Chronic Diabetic Nephropathy Download Download PDF